ASND icon

Ascendis Pharma
ASND

Overview Fund Activity

147 hedge funds and large institutions have $5.45B invested in Ascendis Pharma in 2020 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 44 increasing their positions, 58 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
147
Holders Change
+4
Holders Change %
+2.8%
% of All Funds
3.25%
Holding in Top 10
10
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-33.33%
% of All Funds
0.22%
New
27
Increased
44
Reduced
58
Closed
22
Calls
$50.7M
Puts
$21.8M
Net Calls
+$28.9M
Net Calls Change
-$46.4M

Top Buyers

1
VC
Vivo Capital
California
$226M
2
RCM
RA Capital Management
Massachusetts
$553M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
$210M
4
Artisan Partners
Artisan Partners
Wisconsin
$288M
5
PI
Putnam Investments
Massachusetts
$64.1M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$810M
2
MWNA
Marshall Wace North America
New York
$20.4M
3
Millennium Management
Millennium Management
New York
$30.4M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$359K
5
CAM
Cormorant Asset Management
Massachusetts
$28.2M
Name Holding Trade Value Shares
Change 		Shares
Change %
Renaissance Technologies
51
Renaissance Technologies
New York
$5.75M +$2.39M +21,235 +71%
Goldman Sachs
52
Goldman Sachs
New York
$5.01M +$2.91M +25,819 +139%
Ensign Peak Advisors
53
Ensign Peak Advisors
Utah
$4.84M -$716K -6,356 -13%
Adage Capital Partners
54
Adage Capital Partners
Massachusetts
$4.5M – – –
Geode Capital Management
55
Geode Capital Management
Massachusetts
$4.22M +$539K +4,785 +15%
Allianz Asset Management
56
Allianz Asset Management
Germany
$4.18M -$156K -1,385 -4%
JPMorgan Chase & Co
57
JPMorgan Chase & Co
New York
$4.04M +$1.99M +17,705 +97%
DCM
58
DAFNA Capital Management
California
$3.8M +$635K +5,637 +20%
SFM
59
Sphera Funds Management
Israel
$3.67M -$4.64M -41,200 -56%
PC
60
Polar Capital
United Kingdom
$3.54M -$2.09M -18,557 -37%
AIP
61
ARS Investment Partners
New York
$3.46M +$1.76M +15,669 +104%
ACM
62
Asymmetry Capital Management
California
$3.17M +$2.43M +21,610 +330%
Mirae Asset Global Investments
63
Mirae Asset Global Investments
South Korea
$2.41M +$429K +3,813 +22%
Marshall Wace
64
Marshall Wace
United Kingdom
$2.39M +$2.18M +19,311 +998%
HJIM
65
Henry James International Management
New York
$2.29M +$1.35M +11,962 +142%
D.E. Shaw & Co
66
D.E. Shaw & Co
New York
$2.25M +$2M +17,750 +789%
Nuveen Asset Management
67
Nuveen Asset Management
Illinois
$1.99M +$123K +1,092 +7%
Bank of America
68
Bank of America
North Carolina
$1.92M +$615K +5,458 +47%
Comerica Bank
69
Comerica Bank
Texas
$1.82M +$1.51M +11,671 +484%
Schroder Investment Management Group
70
Schroder Investment Management Group
United Kingdom
$1.72M +$5.44K +46 +0.3%
State Street
71
State Street
Massachusetts
$1.69M -$9.07M -80,566 -84%
SCM
72
Sio Capital Management
New York
$1.56M +$1.56M +13,889 New
IBT
73
International Biotechnology Trust
United Kingdom
$1.55M – – –
MAP
74
Moody Aldrich Partners
Massachusetts
$1.54M -$500K -4,442 -24%
AR
75
Advisory Research
Illinois
$1.49M -$306K -2,713 -17%
1 2
3
4 5